Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Dupilumab Recombinant Human Monoclonal Antibody, Invitrogen™

Human Recombinant Monoclonal Antibody

Supplier:  Thermo Scientific MA541985

Encompass

Catalog No. PIMA541985


Only null left
Add to Cart
This item is not returnable. View return policy

Description

Description

Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 °C for one week. Store at -20 to -80 °C for twelve months from the date of receipt.

Dupilumab with trade name Dupixent, is an FDA-approved drug for the treatment of patients aged 6 years and older with moderate-to-severe atopic dermatitis. It is a human monoclonal antibody. Dupilumab binds to the interleukin-4 receptor alpha (IL-4R alpha) subunit shared by the interleukin (IL)-4 and IL-13 receptor complexes, thereby inhibiting IL-4 and IL-13 signaling.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Dupilumab
Recombinant Monoclonal
Unconjugated
Dupixent; REGN668; SAR231893
Human IL4R/CD124
100 μg
Primary
-20° C, Avoid Freeze/Thaw Cycles
Liquid
Chemical
ELISA, SDS-Page
2.1 mg/mL
PBS with no preservative; pH 7.4
Human
Protein A
RUO
Chemical
Antibody
IgG4 κ
Product Suggestions

Product Suggestions

Videos
Safety and Handling

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov
SDS
Documents

Documents

One moment while we fetch your results.
Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title
Dupilumab Recombinant Human Monoclonal Antibody, Invitrogen™ > 100 μg; Unconjugated

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.